¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023 ´ëÇѾฮÇÐȸ Á¦75Â÷ Ãß°èÇмú´ëȸ(2ÀÏÂ÷) : 2023-11-07

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023 ´ëÇѾฮÇÐȸ Á¦75Â÷ Ãß°èÇмú´ëȸ(2ÀÏÂ÷) : 2023-11-07
±³À°ÀÏÀÚ : 2023-11-07
±³À°Àå¼Ò : ´ëÀüÄÁº¥¼Ç¼¾ÅÍ Á¦1Àü½ÃÀå 2Ãþ ±×·£µåº¼·ë, 204-205È£

±³À°ÁÖÁ¦ : 2023 ´ëÇѾฮÇÐȸ Á¦75Â÷ Ãß°èÇмú´ëȸ(2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѾฮÇÐȸ
´ã´çÀÚ : ½Å¼öÀÎ
¿¬¶ôó : 02-326-0370  

À̸ÞÀÏ : head@kosphar.org

±³À°Á¾·ù : »ý¸®ÇÐ, ¾à¸®ÇÐ

Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ´ëÀü±¤¿ª½Ã
±³À°½Ã°£ : 11 ½Ã°£ 28ºÐ

¼¼ºÎ¼ö°­·á : 150,000¿ø  

ºñ°í ÆòÀÇ¿ø & Á¤È¸¿ø 15¸¸¿ø, ÁØȸ¿ø (Çлýȸ¿ø) 8¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 09:00~09:20 Comprehensive genomic characterization of Korean advanced pan-cancer patients facilitates personalized »ç°æÇÏ(°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 09:20~09:40 Building human single-cell atlas for disease modelling and cell engineering ¹ÚÁ¾Àº(KAIST ÀÇ°úÇдëÇпø)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 09:40~10:00 Metabolic and functional adaptation of T cells in the tumor microenvironment ÀÓ¼±¾Æ(ÀÌÈ­¿©ÀÚ´ëÇб³ »ý¸í°úÇаú)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 10:00~10:20 Application of single cell mega-atlas in drug target and biomarker discovery ¹ÚÁöȯ(GIST »ý¸í°úÇкÎ)

ÈÞ½Ä 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 10:20~10:30 ÈÞ½Ä ()

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 10:30~11:10 Acquired epithelial WNT secretion drives niche independence of developing gastric cancer ±¸º»°æ(IBS)

Åä·Ð 11¿ù 07ÀÏ 207-211È£ 11:10~12:00 Poster Presentation ()

½Ä»ç 11¿ù 07ÀÏ 204-205È£ 12:00~13:00 ÆòÀÇ¿øȸ & ½Ä»ç ¸íâ¼±(Ãæ³²´ëÇб³ ¾àÇдëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 13:00~13:20 Successful Drug Repositioning for Rare Genetic Disease À̹üÈñ(¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 13:20~13:40 The role of TET enzymes in Cancer Immunotherapy ¼­Çü¼®(¼­¿ï´ëÇб³ ¾àÇдëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 13:40~14:00 Divalent oligonucleotides are bioavailable in the lung and efficiently block SARS-CoV-2 infection ½Å¹Î¿í(¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇдëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 14:00~14:20 CLDN18.2-targeting ADC for gastric cancers prepared by AbClick¢â Pro Á¤»óÀü(¼º±Õ°ü´ëÇб³ ¾àÇдëÇÐ)

ÈÞ½Ä 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 14:20~14:30 ÈÞ½Ä ()

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 14:30~15:10 The Interactions between eosinophils and mast cells (THE Allergic Effector Unit)as the ultimate pro-inflammatory cross-talk? Francesca Levi-Schaffer(Hebrew University of Jerusalem, Israel)

ÈÞ½Ä 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 15:10~15:20 ÈÞ½Ä ()

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 15:20~15:50 SREBP-1c regulates hepatic fibrosis via regulating lipocalin-2 expression in NASH Àӽ¼ø(°è¸í´ë ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 15:50~16:20 Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis Á¤¿µ¹Ì(ºÎ»ê´ëÇб³ ÀÚ¿¬°úÇдëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 16:20~16:50 New roles of G12 family proteins in cellular metabolisms ±èÅÂÇö(¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇдëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ ±×·£µåº¼·ë(201È£) 16:50~17:20 Understanding of human diseases in fuel metabolismperspective using the state-of-the art-metabolomicstechniques ÃÖµ¿¿í(°í·Á´ëÇб³ »ý¸í°øÇкÎ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 09:00~09:20 The functional analysis of DDX41 in DNA damage response pathway ±èÈ«ÅÂ(UNIST)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 09:20~09:40 Role of HDAC6 in induced resistance of NSCLCs against radiation therapy ±è¿ì¿µ(¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇкÎ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 09:40~10:00 Mechanisms that limit replication fork stress and genomic instability ±â¿µÈÆ(DGIST)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 10:00~10:20 Bromodomain proteins are protectors against endogenous DNA damage ±èÀçÁø(ÇѸ²´ëÇб³ »ý¸í°úÇаú)

ÈÞ½Ä 11¿ù 07ÀÏ 204-205È£ 10:20~11:10 ÈÞ½Ä ()

½Ä»ç 11¿ù 07ÀÏ 204-205È£ 12:00~13:00 ÆòÀÇ¿øȸ & ½Ä»ç ¸íâ¼±(Ãæ³²´ëÇб³ ¾àÇдëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 13:00~13:13 Successful Drug Repositioning for Rare Genetic Disease ·ùÁÖÈñ(¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 13:13~13:26 The role of TET enzymes in Cancer Immunotherapy À±¼Ò¹Ì(¼­¿ï´ëÇб³ ¾àÇдëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 13:26~13:39 Divalent oligonucleotides are bioavailable in the lung and efficiently block SARS-CoV-2 infection ÇÑÁÖÈñ(¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇдëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 13:39~13:52 CLDN18.2-targeting ADC for gastric cancers prepared by AbClick¢â Pro ½Å¹Î±Ô(¼º±Õ°ü´ëÇб³ ¾àÇдëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 13:52~14:05 Optical sensing and control of protein activity for the study of brain diseases ¼ºÁöÇý(¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 14:05~14:18 First-in-Human Study of J2H-1702, a Novel 11¥â-hydroxysteroid Dehydrogenase Type 1 Inhibitor ÀÌ»ó¿ø(ÇѾç´ëÇб³ ÀÇ°ú´ëÇÐ)

ÈÞ½Ä 11¿ù 07ÀÏ 204-205È£ 14:18~15:20 ÈÞ½Ä ()

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 15:20~15:50 SREBP-1c regulates hepatic fibrosis via regulating lipocalin-2 expression in NASH °­Á¾¼ø(¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 15:50~16:20 Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis À±¹Ì¼·(°¡Ãµ´ëÇб³ ÀÇ°ú´ëÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 16:20~16:50 New roles of G12 family proteins in cellular metabolisms ±èÇö¿ì(KAIST »ý¸í°úÇÐ)

±³À°½Ã°£ 11¿ù 07ÀÏ 204-205È£ 16:50~17:20 Understanding of human diseases in fuel metabolismperspective using the state-of-the art-metabolomicstechniques ¹è±Ô¿î(¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇдëÇÐ)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023 ´ëÇѾฮÇÐȸ Á¦75Â÷ Ãß°èÇмú´ëȸ(2ÀÏÂ÷) : 2023-11-07""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °æ»ó±¹¸³´ëÇб³º´¿ø ¼­ºÎ°æ³² À̺ñÀÎÈÄ°ú Áý´ãȸ : 2023-11-08
´ÙÀ½±Û 2023³âµµ ºÐ´ç¼­¿ï´ëÇб³º´¿ø Á¤½Å°Ç°­ÀÇÇаú ¿¬¼ö°­Á : 2023-11-07
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 76 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 41 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 49 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 57 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 45 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 46 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 22 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 18 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 46 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 22 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 49 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 31 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 35 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 29 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷